January 2019
Corporate | Financial January 17, 2019
Symrise updates long-term targets and aims to further expand its business until 2025
— Target corridor of 5 to 7 % for average annual sales growth (CAGR)
— Increased profitability with EBITDA margin in the range of 20 to 23 % from 2020 onward
— Continuation of successful strategy
— Expansion of portfolio and sharpening the product mix: focus on high-margin applications
— Updated targets for sustainability balance planned.
Corporate | Financial January 31, 2019
Symrise strengthens Pet Food activities and expands US footprint with acquisition of ADF/IDF
— ADF/IDF is a leading meat and egg-based protein specialist and pioneer in all
natural nutrition ingredients generating annual sales of $ 220 million
— The nutrition and taste solutions to the pet food and food segments are highly
complementary to Symrise offerings
— A perfect fit in terms of culture and...
February 2019
Corporate | Financial February 8, 2019
Symrise successfully completes capital increase
— Strong investor demand
— 5.614 million new shares placed
— Gross proceeds amount of € 400 million
— First refinancing element for acquisition of US company ADF/IDF completed
Scent and Care | Corporate | Financial February 22, 2019
Protecting climate, water and forests: Symrise again rated well
— Nonprofit organization CDP awards Symrise A- and B grades
— Symrise is one of the most sustainable companies in its industry
March 2019
Corporate | Financial March 13, 2019
Symrise successfully continues profitable growth course in 2018
— Strong organic sales growth of 8.8 %
— Sales increase of 5.3 % to € 3,154 million (reporting currency)
— Solid earnings with EBITDA at € 631million and EBITDA margin at 20.0 %
— Net income increases to over € 275 million
— Dividend increase to € 0.90 per share proposed
April 2019
Corporate | Financial April 30, 2019
Symrise posts strong growth of 9.3 % in the first quarter
— Group sales rise to € 848.8 million
— Organic growth, adjusted for exchange rate effects, of 8.2 %
— Company reaffirms 2019 guidance and long-term targets until the end of 2025
May 2019
Corporate | Financial May 6, 2019
Symrise acquires Italian biotech company Cutech
— Adds competitive edge in bio-analytical methods
— Expands R&D capacities for the efficacy testing of cosmetic ingredients
— Accelerates the development of active ingredients based on predictive ex vivo models
— Unique pre-clinical screening services provided to the cosmetic industry
Corporate | Financial May 8, 2019
Symrise announces Califormulations, LLC: A unique platform to foster beverage innovation
— End-to-end beverage concepts for the North American market
— A new 100,000 sq ft innovation campus located in Georgia
— Integrated access to Symrise locations
— Focused innovation with high degree of agility and flexibility
Corporate | Financial May 23, 2019
Symrise completes € 500 million bond placement
— Successful placement underscores investors' trust in corporate strategy and financial strength
— Bond issue, with a maturity of 6.5 years, was heavily oversubscribed
— 1.25 % coupon
August 2019
Corporate | Financial August 7, 2019
Dr. Winfried Steeger has been elected as new Chairman of the Symrise Supervisory Board
— Dr. Winfried Steeger succeeds Dr. Thomas Rabe, who is resigning as Chairman of the Supervisory Board at his own request effective 7 August 2019
— Dr. Steeger is a member of the Supervisory Board of Symrise AG since 2012 and has many years of leadership experience and recognized expertise
Corporate | Financial August 8, 2019
Symrise achieves strong revenue growth of 7.4 % in the first half of the year
— Profitability at good level with an EBITDA(N) margin of 20.8 %
— Outlook 2019 specified: Normalized EBITDA margin expected to be around 21 %
— Growth target for the full year and long-term goals for 2025 confirmed